您的位置: 首页 > 农业专利 > 详情页

An isolated antibody that selectively binds to beta-amyloid peptide, a pharmaceutical composition comprising said antibody, nucleic acid sequence, vector and host cell
专利权人:
DELENEX THERAPEUTICS AG;UNIVERSITY ZÜRICH
发明人:
STEFAN EWERT,ADRIAN AUF DER MAUR,SUSAN CATTEPOEL,ROGER NITSCH
申请号:
BRPI0817099
公开号:
BRPI0817099A2
申请日:
2008.09.15
申请国别(地区):
BR
年份:
2015
代理人:
摘要:
The invention discloses an isolated antibody that selectively binds to the C-terminal part of Abeta and is humanized or fully human. The antibody of the invention is capable of preventing oligomerization of Abeta. Furthermore, a method of diagnosis comprising the steps of: (i) Labelling an antibody; (ii) Administering an effective dose of said antibody intranasally or systemically to a subject; and (iii) Detecting the concentration and/or presence of the labelled antibody in body parts of the subject is disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充